Emerging Market Outsourcing Report, Q2 2026

Analyze pharmaceutical outsourcing trends across emerging markets. Explore CMO activity, contract manufacturing, API production, M&A, clinical manufacturing, packaging, supply chain trends, and outsourcing opportunities.

Report Value Proposition – Why Does Pharma Outsourcing Matter?

Pharmaceutical outsourcing continues to play a critical role in helping drug manufacturers improve efficiency, reduce costs, and accelerate product development. As emerging markets expand their manufacturing capabilities, contract manufacturing organizations (CMOs) are becoming increasingly important partners across active pharmaceutical ingredient (API) production, biologics, drug formulation, packaging, and commercial manufacturing.

GlobalData’s Emerging Pharma Market Outsourcing report provides a comprehensive analysis of pharmaceutical manufacturing trends across emerging markets, with a particular focus on CMOs, outsourcing activity, strategic partnerships, mergers and acquisitions, financing, and supply chain developments. The report equips pharmaceutical companies, suppliers, and investors with actionable intelligence to support sourcing, manufacturing, and investment decisions.

You can use this report to:

• Understand pharmaceutical outsourcing trends across emerging markets
• Analyze contract manufacturing organization (CMO) activity
• Evaluate API, biologics, and drug manufacturing capabilities
• Monitor outsourcing partnerships and service agreements
• Assess supply chain developments and regulatory changes
• Support sourcing, procurement, and investment strategies
  

Key Insights in Emerging Pharma Outsourcing

The report explores the major trends shaping pharmaceutical manufacturing and outsourcing across emerging markets.

Key themes include:

• Growth of contract manufacturing organizations (CMOs)
• API manufacturing trends for biologics and chemical products
• Clinical and commercial drug manufacturing developments
• Pharmaceutical packaging and dose manufacturing capabilities
• Strategic outsourcing partnerships and contract agreements
• Mergers, acquisitions, and financing activity among CMOs
• Supply chain resilience and manufacturing investments
• Regulatory developments influencing pharmaceutical outsourcing

Scope

What Will You Learn from This Report?

This report provides insight into:

• Emerging market pharmaceutical outsourcing
• Contract manufacturing trends
• CMO competitive landscape
• API manufacturing capabilities
• Biologics and chemical manufacturing
• Clinical and commercial manufacturing
• Pharmaceutical packaging trends
• M&A and financing activity
• Supply chain developments
• Regulatory and inspection updates

Who Should Buy This Report?

This report is valuable for:

• Pharmaceutical manufacturers
• Contract manufacturing organizations (CMOs)
• Biopharmaceutical companies
• API manufacturers
• Sourcing and procurement teams
• Supply chain professionals
• Business development teams
• Investors and private equity firms
• Market intelligence professionals
• Pharmaceutical consultants
  

  

How Companies Use This Pharma Outsourcing Analysis

Pharmaceutical companies use this report to identify qualified manufacturing partners, evaluate outsourcing opportunities, and strengthen sourcing strategies across emerging markets.

CMOs, procurement teams, and business development professionals leverage the analysis to monitor competitor activity, assess manufacturing investments, identify partnership opportunities, and stay informed about regulatory developments affecting pharmaceutical production.

Investors and consultants also use the report to evaluate market dynamics, track mergers and acquisitions, identify high-growth manufacturing segments, and assess the competitive positioning of leading contract manufacturers.

Reasons to Buy

Benchmark Your Manufacturing Strategy Against Leading CMOs

This report helps organizations benchmark their outsourcing and manufacturing strategies against leading pharmaceutical contract manufacturers.

It provides comparative insight into:

• Contract manufacturing capabilities
• API production trends
• Clinical manufacturing services
• Commercial manufacturing capacity
• Strategic partnerships
• M&A and financing activity
• Supply chain investments
• Competitive positioning

Built on Trusted GlobalData Pharmaceutical Intelligence

GlobalData’s Emerging Pharma Market Outsourcing report is built on proprietary pharmaceutical databases, manufacturing intelligence, clinical trial analysis, regulatory monitoring, financial data, and expert industry research.

Trusted by pharmaceutical manufacturers, CMOs, investors, procurement teams, and consulting firms, GlobalData delivers actionable intelligence that supports manufacturing strategy, supplier selection, competitive benchmarking, and long-term business planning.

GlobalData’s pharmaceutical analysts provide deep expertise across contract manufacturing, biologics, APIs, supply chain management, regulatory affairs, and pharmaceutical outsourcing.

Strengthen Your Outsourcing Strategy in Emerging Pharma Markets

As pharmaceutical companies continue to optimize manufacturing networks and diversify supply chains, organizations that understand evolving outsourcing trends, CMO capabilities, and emerging market opportunities will be better positioned to improve operational efficiency, reduce risk, and build resilient manufacturing strategies for future growth.